Introduction
A cancer diagnosis can feel overwhelming — and for many patients and families, the question that follows is: what are my options? Over the past decade, cancer immunotherapy in Ahmedabad has become one of the most significant advances in oncology, offering new hope where conventional treatments once had limits. Unlike chemotherapy or radiation, immunotherapy works by activating your own immune system to identify and destroy cancer cells — a fundamentally different and often more targeted approach to treatment.
At Zanish Cancer Hospital in Ahmedabad, we understand that every patient’s journey is unique. Our goal is to provide you with medically accurate, honest information so you can make informed decisions about your care. This article explains what cancer immunotherapy is, how it works, who may benefit, what to expect, and how our team supports patients through this treatment pathway.
What Is Cancer Immunotherapy?
The human immune system is designed to detect and eliminate abnormal cells — including, in many cases, cancer cells. However, some cancers develop mechanisms that allow them to evade immune detection. Immunotherapy uses medical interventions to either enhance the immune system’s natural response or remove these evasion mechanisms, enabling the body to fight cancer more effectively.
Immunotherapy is not a single treatment. It is a broad category that includes several distinct approaches, each suited to different cancer types and patient profiles.
Types of Immunotherapy Available at Zanish Cancer Hospital
Checkpoint Inhibitor Therapy
Cancer cells sometimes exploit immune “checkpoints” — regulatory proteins that normally prevent the immune system from attacking healthy tissue. Checkpoint inhibitor therapy uses drugs to block these proteins, such as PD-1, PD-L1, and CTLA-4, thereby allowing immune cells to recognise and attack tumours.
Checkpoint inhibitors have demonstrated strong clinical results in cancers including melanoma, non-small cell lung cancer, bladder cancer, and certain head and neck cancers. They are among the most widely studied immunotherapy options in oncology today.
CAR-T Cell Therapy
Chimeric Antigen Receptor T-cell (CAR-T) therapy is a more advanced, personalised form of biological cancer treatment. In this approach, a patient’s own T-cells are extracted, genetically engineered in a laboratory to recognise specific cancer antigens, and then reinfused into the patient’s bloodstream. These modified cells are designed to seek out and destroy cancer cells with greater precision.
CAR-T cell therapy has shown particular promise in certain blood cancers, including some forms of leukaemia and lymphoma. It represents one of the most innovative developments in immune oncology Gujarat patients can now access closer to home.
Monoclonal Antibodies
These laboratory-produced proteins are designed to attach to specific targets on cancer cells. Some work by marking cancer cells for destruction by the immune system; others directly interfere with cancer cell growth. Monoclonal antibodies are used across a wide range of cancer types and are often combined with other treatments.
Cancer Vaccines
Therapeutic cancer vaccines are designed to stimulate the immune system against cancer cells already present in the body. Unlike preventive vaccines, these are used as a treatment strategy and are an active area of clinical research.
Cytokines
Cytokine therapy uses proteins such as interleukins and interferons to stimulate immune activity. While effective in specific contexts, cytokine treatments require careful monitoring due to their systemic effects.
Who May Benefit from Immunotherapy?
Immunotherapy is not universally appropriate for all cancer patients. Eligibility depends on several factors, including:
- The type and stage of cancer
- The presence of specific biomarkers (e.g., PD-L1 expression, tumour mutational burden)
- Prior treatment history
- Overall health and immune function
- Genetic markers identified through molecular testing
Before recommending immunotherapy, the oncology team at Zanish Cancer Hospital conducts comprehensive diagnostic evaluations, including biomarker testing, to determine whether a patient is likely to respond well to immune-based treatments.
Understanding Immunotherapy Side Effects
Immunotherapy side effects differ from those typically associated with chemotherapy. Because these treatments stimulate immune activity, the side effects are often immune-related rather than directly toxic to healthy cells. Common side effects may include:
- Fatigue
- Skin reactions (rash, itching)
- Flu-like symptoms
- Diarrhoea or colitis
- Endocrine disruptions (thyroid or adrenal gland effects)
- In rare cases, more serious inflammation in the lungs, liver, or kidneys
Most immune-related side effects are manageable with proper medical supervision, and many patients tolerate immunotherapy significantly better than traditional chemotherapy. However, close monitoring and prompt reporting of any new symptoms are essential throughout treatment.
Local Healthcare Context: Immunotherapy Access in Gujarat
Historically, patients in Gujarat seeking advanced biological cancer treatment often had to travel to metropolitan centres outside the state. This presented significant challenges — financial burden, disruption to family life, and delayed access to care.
Zanish Cancer Hospital was established with a clear purpose: to bring internationally benchmarked cancer care to Ahmedabad and the wider Gujarat region. Access to immune oncology in Gujarat no longer requires travelling to Mumbai or Delhi. Patients from across the state — including Surat, Vadodara, Rajkot, and Gandhinagar — now have a specialist oncology centre within reachable distance.
This local accessibility is particularly meaningful for elderly patients, those with limited mobility, and families who need to remain actively involved in a patient’s care.
Zanish Cancer Hospital's Approach to Immunotherapy
At Zanish Cancer Hospital, cancer immunotherapy is delivered through a structured, multidisciplinary framework. Our team includes medical oncologists, haematologists, clinical immunologists, and supportive care specialists who collaborate on each patient case.
Our capabilities include:
- Biomarker and molecular testing to assess immunotherapy eligibility
- Administration of checkpoint inhibitor therapies approved for relevant cancer types
- CAR-T cell therapy coordination and patient monitoring
- Monoclonal antibody treatments integrated into comprehensive care plans
- Immune-related adverse event (irAE) management and monitoring protocols
- Psychological support and patient counselling throughout treatment
We follow evidence-based protocols aligned with national and international oncology guidelines. Our approach prioritises patient safety, treatment accuracy, and transparent communication at every stage of care.
We believe that informed patients make better decisions. Our clinical team takes the time to explain treatment rationale, expected outcomes, potential side effects, and realistic goals — so that patients and their families can engage meaningfully in the care process.
Conclusion & Next Steps
Cancer immunotherapy represents one of the most meaningful advances in oncology in recent decades. For eligible patients, it offers a targeted, biologically grounded approach to treatment — one that harnesses the body’s own defences rather than relying solely on external interventions. From checkpoint inhibitor therapy to CAR-T cell therapy, the range of available options continues to grow alongside the evidence supporting their use.
If you or a family member has received a cancer diagnosis and would like to understand whether immunotherapy may be appropriate, the right first step is a specialist consultation. A qualified oncologist can assess your specific situation, review diagnostic results, and provide guidance grounded in current medical evidence.
Zanish Cancer Hospital welcomes patients from Ahmedabad and across Gujarat for consultations. To schedule an appointment or speak with a member of our oncology team, please contact us directly. Early evaluation leads to better options — and we are here to help you navigate yours.
Disclaimer: This article is intended for informational purposes only and does not constitute medical advice. Cancer treatment decisions should always be made in consultation with a qualified oncologist who can assess your individual clinical situation.
Make Appointment
Address
1st Floor, Viva Atelier, Opp. B.D. Patel House, Near Sardar Patel Statue, Behind Sardar Patel Colony, Naranpura, Ahmedabad-380014. (Gujarat) India
Contact Us
+91 7433852300